跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEVIKAR HCT 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
SEVIKAR HCT 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack
Approved
STANDARD
SEVIKAR HCT 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack
ORGANON PHARMA PTY LTD
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
556b5c96a51d0bbd
Company
ORGANON PHARMA PTY LTD
Type
Standard
Approval Details
Approval Id
556b5c96a51d0bbd
Product Name
SEVIKAR HCT 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack
Artg Id
198998
Artg Name
SEVIKAR HCT 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack
Sponsor
ORGANON PHARMA PTY LTD
Company Detail Path
/organization/organon-pharma-pty-ltd
Artg Date
2013-09-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/7536d42281e7564846cc16d6803a0695.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/795066df9370b1fa35a51e1763e319da.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
556b5c96a51d0bbd
Type
Standard
Back to TGA Approvals